NARDONE, Gerardo
NARDONE, Gerardo
DIPARTIMENTO DI MEDICINA CLINICA E CHIRURGIA
Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis
1999 Nardone, GERARDO ANTONIO PIO; Staibano, Stefania; Rocco, A; Mezza, E; D'Armiento, FRANCESCO PAOLO; Insabato, Luigi; Coppola, A; Salvatore, G; Lucariello, A; Figura, N; DE ROSA, Gaetano; Budillon, G.
Lipids of human gastric mucosa: effect of helicobacter pylori infection and nonalcoholic cirrhosis
1994 Nardone, GERARDO ANTONIO PIO; D'Armiento, FRANCESCO PAOLO; Corso, G.; Coscione, P.; Budillon, G.
VITAMIN B12 SUPPLEMENTATION IMPROVES SUSTAINED-VIRAL-RESPONSE RATES IN HEPATITIS C VIRUS GENOTYPE 1B-INFECTED PATIENTS
2012 Rocco, Alba; Compare, Debora; V., Varriale; O. M., Nardone; M., Sanduzzi Zamparelli; Nardone, GERARDO ANTONIO PIO
Cox-2 and NF-KB expression in gastric mucosa is influenced by peroxisome proliferator –activated receptor-gamma polymorphisms.
2009 Compare, Debora; Rocco, Alba; C., Flora; E., Liguori; F., Fusco; P., De Colibus; L., Pica; A., Sapone; D., Vaira; Nardone, GERARDO ANTONIO PIO
CUTE E MALATTIE GASTROINTESTINALI
2006 Nardone, GERARDO ANTONIO PIO
Peroxisome proliferator-activated receptor-gamma influence the expression of cyclo-oxygenase-2 and NF-kB in inflamed gastric mucosa.
2008 Rocco, Alba; A., Sapone; E., Liguori; Compare, Debora; F., Caruso; P., Decolibus; F., Fusco; D., Vaira; Nardone, GERARDO ANTONIO PIO
Reversibility of histologic alterations and genomic instability after Helicobacter pylori eradication
1999 Nardone, GERARDO ANTONIO PIO; Rocco, Alba; Staibano, Stefania; D'Armiento, FRANCESCO PAOLO; T., Balzano; G., De Rosa; G., Budillon
Does Helicobacter pylori eradication revert histologic alterations and genomic instability markers?
1998 Nardone, GERARDO ANTONIO PIO; Rocco, Alba; Staibano, Stefania; T., Balzano; A., Salvato; G., De Rosa; G. B. u. d. i. l. l. o., N.
Molecular basis of colonrectal carcinogenesis
2003 Nardone, GERARDO ANTONIO PIO
Protective effects of probiotic administration on SIBO development and bowel symptom onset in GERD patients at long-term PPI treatment: a randomized controlled cross-sectional study
2011 Nardone, GERARDO ANTONIO PIO
P-gp protects gastric mucosa from apoptosis by interacting with bcl-xL: an in vivo and in vitro study
2011 Rocco, Alba; Compare, Debora; E., Liguori; G., De Nucci; O. M., Nardone; M., Sanduzzi Zamparelli; M., Sica; Nardone, GERARDO ANTONIO PIO
Carico combinato di xilosio (D-xyl) e 3-o-metilglucosio (3-omG) nello studio dell’assorbimento intestinale.
1984 Parrilli, G; Cuomo, Rosario; Nardone, GERARDO ANTONIO PIO; Budillon, G.
L’Epatocarcinoma: aspetti clinici e prognostici.
1989 Cimino, L; Capuano, G; Nardone, GERARDO ANTONIO PIO; Cuomo, Rosario; Topa, M; Budillon, G.
Do PPI have a significant role in the cure of ENT symtomps related to GERD
2003 Nardone, GERARDO ANTONIO PIO
POLIPOSI FAMILIARE DEL COLONGESTIONE RISCHIO & SORVEGLIANZA
2010 Nardone, GERARDO ANTONIO PIO
Gastric Cancer: Is Chemoprevention Feasible and Effective?
2010 Nardone, GERARDO ANTONIO PIO
Barrett’s Debate: Chemoprevention Yes
2005 Nardone, GERARDO ANTONIO PIO
Incontri di Gastroenterologia
2007 Nardone, GERARDO ANTONIO PIO
Genetic predisposition and molecular pathways to upper GI cancer
2007 Nardone, GERARDO ANTONIO PIO
NF-KB modulation and anti-apoptotic effects of IL-13 in gastric adenocarcinoma epithelial cell lines
2007 B., Marotti; DE COLIBUS, Patrizia; G., DE NUCCI; Compare, Debora; G., Autiero; Rocco, Alba; Nardone, GERARDO ANTONIO PIO
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis | 1.1 Articolo in rivista | 1999 | Nardone, GERARDO ANTONIO PIO; Staibano, Stefania; Rocco, A; Mezza, E; D'Armiento, FRANCESCO PAOLO; Insabato, Luigi; Coppola, A; Salvatore, G; Lucariello, A; Figura, N; DE ROSA, Gaetano; Budillon, G. | |
| Lipids of human gastric mucosa: effect of helicobacter pylori infection and nonalcoholic cirrhosis | 1.1 Articolo in rivista | 1994 | Nardone, GERARDO ANTONIO PIO; D'Armiento, FRANCESCO PAOLO; Corso, G.; Coscione, P.; Budillon, G. | |
| VITAMIN B12 SUPPLEMENTATION IMPROVES SUSTAINED-VIRAL-RESPONSE RATES IN HEPATITIS C VIRUS GENOTYPE 1B-INFECTED PATIENTS | 1.5 Abstract in rivista | 2012 | Rocco, Alba; Compare, Debora; V., Varriale; O. M., Nardone; M., Sanduzzi Zamparelli; Nardone, GERARDO ANTONIO PIO | |
| Cox-2 and NF-KB expression in gastric mucosa is influenced by peroxisome proliferator –activated receptor-gamma polymorphisms. | 1.5 Abstract in rivista | 2009 | Compare, Debora; Rocco, Alba; C., Flora; E., Liguori; F., Fusco; P., De Colibus; L., Pica; A., Sapone; D., Vaira; Nardone, GERARDO ANTONIO PIO | |
| CUTE E MALATTIE GASTROINTESTINALI | 8.02 Comunicazioni a Convegni o Seminari | 2006 | Nardone, GERARDO ANTONIO PIO | |
| Peroxisome proliferator-activated receptor-gamma influence the expression of cyclo-oxygenase-2 and NF-kB in inflamed gastric mucosa. | 1.5 Abstract in rivista | 2008 | Rocco, Alba; A., Sapone; E., Liguori; Compare, Debora; F., Caruso; P., Decolibus; F., Fusco; D., Vaira; Nardone, GERARDO ANTONIO PIO | |
| Reversibility of histologic alterations and genomic instability after Helicobacter pylori eradication | 1.5 Abstract in rivista | 1999 | Nardone, GERARDO ANTONIO PIO; Rocco, Alba; Staibano, Stefania; D'Armiento, FRANCESCO PAOLO; T., Balzano; G., De Rosa; G., Budillon | |
| Does Helicobacter pylori eradication revert histologic alterations and genomic instability markers? | 1.5 Abstract in rivista | 1998 | Nardone, GERARDO ANTONIO PIO; Rocco, Alba; Staibano, Stefania; T., Balzano; A., Salvato; G., De Rosa; G. B. u. d. i. l. l. o., N. | |
| Molecular basis of colonrectal carcinogenesis | 4.1 Articoli in Atti di convegno | 2003 | Nardone, GERARDO ANTONIO PIO | |
| Protective effects of probiotic administration on SIBO development and bowel symptom onset in GERD patients at long-term PPI treatment: a randomized controlled cross-sectional study | 8.03 Conv. e contr. di ricerca di Enti Pubblici/Privati | 2011 | Nardone, GERARDO ANTONIO PIO | |
| P-gp protects gastric mucosa from apoptosis by interacting with bcl-xL: an in vivo and in vitro study | 1.5 Abstract in rivista | 2011 | Rocco, Alba; Compare, Debora; E., Liguori; G., De Nucci; O. M., Nardone; M., Sanduzzi Zamparelli; M., Sica; Nardone, GERARDO ANTONIO PIO | |
| Carico combinato di xilosio (D-xyl) e 3-o-metilglucosio (3-omG) nello studio dell’assorbimento intestinale. | 2.1 Contributo in volume (Capitolo o Saggio) | 1984 | Parrilli, G; Cuomo, Rosario; Nardone, GERARDO ANTONIO PIO; Budillon, G. | |
| L’Epatocarcinoma: aspetti clinici e prognostici. | 2.1 Contributo in volume (Capitolo o Saggio) | 1989 | Cimino, L; Capuano, G; Nardone, GERARDO ANTONIO PIO; Cuomo, Rosario; Topa, M; Budillon, G. | |
| Do PPI have a significant role in the cure of ENT symtomps related to GERD | 4.1 Articoli in Atti di convegno | 2003 | Nardone, GERARDO ANTONIO PIO | |
| POLIPOSI FAMILIARE DEL COLONGESTIONE RISCHIO & SORVEGLIANZA | 8.02 Comunicazioni a Convegni o Seminari | 2010 | Nardone, GERARDO ANTONIO PIO | |
| Gastric Cancer: Is Chemoprevention Feasible and Effective? | 8.02 Comunicazioni a Convegni o Seminari | 2010 | Nardone, GERARDO ANTONIO PIO | |
| Barrett’s Debate: Chemoprevention Yes | 8.02 Comunicazioni a Convegni o Seminari | 2005 | Nardone, GERARDO ANTONIO PIO | |
| Incontri di Gastroenterologia | 8.02 Comunicazioni a Convegni o Seminari | 2007 | Nardone, GERARDO ANTONIO PIO | |
| Genetic predisposition and molecular pathways to upper GI cancer | 8.02 Comunicazioni a Convegni o Seminari | 2007 | Nardone, GERARDO ANTONIO PIO | |
| NF-KB modulation and anti-apoptotic effects of IL-13 in gastric adenocarcinoma epithelial cell lines | 1.5 Abstract in rivista | 2007 | B., Marotti; DE COLIBUS, Patrizia; G., DE NUCCI; Compare, Debora; G., Autiero; Rocco, Alba; Nardone, GERARDO ANTONIO PIO |